FAP and neoplasm: A prospective exploratory imaging clinical trial with 68Ga-FAPi-46 PET demonstrated that tracer uptake and biodistribution across multiple cancers strongly correlated with FAP expression of surgically excised tumor and metastasis tissues [222].